甲状腺髓样癌中的增殖细胞核抗原（PCNA）
Proliferating cell nuclear antigen (PCNA) in medullary thyroid carcinoma.
作者信息
Skopelitou A, Korkolopoulou P, Papanikolaou A, Hadjiyannakis M
机构信息
Pathology Department, Asklepeion Hospital, Voula Attikis, Greece.
出版信息
J Cancer Res Clin Oncol. 1993;119(7):379-81. doi: 10.1007/BF01218417.
Abstract
We investigated the expression of proliferating cell nuclear antigen (PCNA) in paraffin sections from 20 cases of medullary thyroid carcinoma (MTC). Follow-up data were available in eleven cases. PCNA index positively correlated with the degree of cellular pleomorphism (grade) of the tumor (p < 0.01), the pathologic stage (p < 0.01) and the poor clinical outcome (p < 0.05). These findings suggest that PCNA may be of prognostic significance in MTC.
摘要
我们研究了20例甲状腺髓样癌（MTC）石蜡切片中增殖细胞核抗原（PCNA）的表达情况。11例患者有随访数据。PCNA指数与肿瘤的细胞多形性程度（分级）（p < 0.01）、病理分期（p < 0.01）及不良临床结局（p < 0.05）呈正相关。这些发现提示PCNA在MTC中可能具有预后意义。
相似文献
1
Proliferating cell nuclear antigen (PCNA) in medullary thyroid carcinoma.甲状腺髓样癌中的增殖细胞核抗原（PCNA）
J Cancer Res Clin Oncol. 1993;119(7):379-81. doi: 10.1007/BF01218417.
2
[Proliferating cell nuclear antigen/cyclin (PCNA/Cyclin) in thyroid carcinoma].甲状腺癌中的增殖细胞核抗原/细胞周期蛋白（PCNA/Cyclin）
Zhonghua Wai Ke Za Zhi. 1993 Oct;31(10):628-9.
3
The clinical utility of the proliferating cell nuclear antigen expression in patients with hepatocellular carcinoma.增殖细胞核抗原表达在肝细胞癌患者中的临床应用价值。
Tumour Biol. 2016 Jun;37(6):7405-12. doi: 10.1007/s13277-015-4582-9. Epub 2015 Dec 17.
4
Relationship of CD15 immunoreactivity and prognosis in sporadic medullary thyroid carcinoma.散发性甲状腺髓样癌中CD15免疫反应性与预后的关系
J Cancer Res Clin Oncol. 1992;118(8):629-34. doi: 10.1007/BF01211810.
5
Assessment of proliferating-cell nuclear antigen immunostaining in soft-tissue tumours: relationship to histological grade and mitotic activity.软组织肿瘤中增殖细胞核抗原免疫染色的评估：与组织学分级和有丝分裂活性的关系。
J Cancer Res Clin Oncol. 1994;120(7):393-8. doi: 10.1007/BF01240137.
6
Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer.增殖细胞核抗原（PC10）免疫标记及其他增殖指标作为乳腺癌的预后因素
J Cancer Res Clin Oncol. 1993;119(5):288-94. doi: 10.1007/BF01212727.
7
Argyrophilic nucleolar organizer region counts and proliferating cell nuclear antigen scores are two reliable indicators of survival in pharyngeal carcinoma.嗜银核仁组织区计数和增殖细胞核抗原评分是咽癌生存的两个可靠指标。
J Cancer Res Clin Oncol. 1992;119(2):106-10. doi: 10.1007/BF01209665.
8
Immunohistochemical demonstration of proliferating cell nuclear antigen in glioblastomas: pronounced heterogeneity and lack of prognostic significance.胶质母细胞瘤中增殖细胞核抗原的免疫组织化学显示：明显的异质性及缺乏预后意义
J Cancer Res Clin Oncol. 1992;118(4):289-95. doi: 10.1007/BF01208618.
9
Clinical relevance of p53 index and expression of proliferating cell nuclear antigen and Ki-67 in gastric cancer.p53指数以及增殖细胞核抗原和Ki-67在胃癌中的表达的临床相关性
J Cancer Res Clin Oncol. 1998;124(9):497-502. doi: 10.1007/s004320050205.
10
Proliferative activity of human thyroid tumors evaluated by proliferating cell nuclear antigen/cyclin immunohistochemical studies.通过增殖细胞核抗原/细胞周期蛋白免疫组织化学研究评估人类甲状腺肿瘤的增殖活性。
Cancer. 1993 May 1;71(9):2807-12. doi: 10.1002/1097-0142(19930501)71:9<2807::aid-cncr2820710920>3.0.co;2-5.
引用本文的文献
1
Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome.基于肿瘤坏死和高有丝分裂率对髓样甲状腺癌进行分级是预后不良的独立预测因子。
Mod Pathol. 2020 Sep;33(9):1690-1701. doi: 10.1038/s41379-020-0532-1. Epub 2020 Apr 20.
2
Proliferation Markers and Their Uses in the Study of Endocrine Tumors.增殖标志物及其在内分泌肿瘤研究中的应用
Endocr Pathol. 1996 Summer;7(2):103-119. doi: 10.1007/BF02739970.
3
Assessment of proliferating-cell nuclear antigen immunostaining in soft-tissue tumours: relationship to histological grade and mitotic activity.软组织肿瘤中增殖细胞核抗原免疫染色的评估：与组织学分级和有丝分裂活性的关系。
J Cancer Res Clin Oncol. 1994;120(7):393-8. doi: 10.1007/BF01240137.
本文引用的文献
1
Medullary carcinoma of the thyroid in the multiple endocrine neoplasia IIA syndrome.多发性内分泌腺瘤病IIA综合征中的甲状腺髓样癌。
Am J Surg Pathol. 1981 Jul;5(5):459-72. doi: 10.1097/00000478-198107000-00005.
2
The prognostic value of calcitonin immunostaining in medullary carcinoma of the thyroid.降钙素免疫染色在甲状腺髓样癌中的预后价值。
J Clin Endocrinol Metab. 1984 Nov;59(5):850-6. doi: 10.1210/jcem-59-5-850.
3
The significance of mitotic rate: a retrospective study of 127 thyroid carcinomas.有丝分裂率的意义：127例甲状腺癌的回顾性研究
Hum Pathol. 1985 Oct;16(10):1042-6. doi: 10.1016/s0046-8177(85)80282-3.
4
Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase.培养细胞中核蛋白细胞周期蛋白增殖细胞核抗原分布的细胞周期依赖性变化：S期的细分
Proc Natl Acad Sci U S A. 1985 May;82(10):3262-6. doi: 10.1073/pnas.82.10.3262.
5
Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content.甲状腺髓样癌的预后因素。生存与年龄、性别、分期、组织学、免疫细胞化学及DNA含量的关系。
Cancer. 1988 Feb 15;61(4):806-16. doi: 10.1002/1097-0142(19880215)61:4<806::aid-cncr2820610428>3.0.co;2-g.
6
Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens.甲状腺髓样癌。一项使用六种不同抗原的免疫组织化学和体液研究。
Am J Clin Pathol. 1991 Mar;95(3):300-8. doi: 10.1093/ajcp/95.3.300.
7
Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.石蜡切片中增殖细胞核抗原（PCNA）的免疫定位：一种细胞增殖指标，在某些肿瘤中存在表达失调的证据。
J Pathol. 1990 Dec;162(4):285-94. doi: 10.1002/path.1711620403.
8
The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis.原发性胃肠道淋巴瘤中增殖细胞核抗原（PCNA）免疫染色的评估及其与组织学分级、S+G2+M期细胞比例（流式细胞术分析）和预后的关系。
Histopathology. 1991 Jul;19(1):21-7. doi: 10.1111/j.1365-2559.1991.tb00890.x.
9
Prognostic value of proliferating cell nuclear antigen in gastric carcinoma.增殖细胞核抗原在胃癌中的预后价值
J Clin Pathol. 1991 Aug;44(8):655-9. doi: 10.1136/jcp.44.8.655.
Zotero 插件